Stay updated on Pegilodecakin Combo vs Pembrolizumab Alone in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Pegilodecakin Combo vs Pembrolizumab Alone in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pegilodecakin Combo vs Pembrolizumab Alone in NSCLC Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    No substantive updates were detected; the Study Details, Eligibility Criteria, Interventions, and Outcome measures appear unchanged between versions.
    Difference
    0.3%
    Check dated 2025-11-03T12:42:14.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    37 days ago
    Change Detected
    Summary
    Update includes a critical operating status notice and a new software version (v3.2.0), indicating updated deployment with potential service impact; previous version reference (v3.1.0) was removed.
    Difference
    3%
    Check dated 2025-10-05T17:30:24.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    Version bump from v3.0.2 to v3.1.0; no other content changes detected.
    Difference
    0.1%
    Check dated 2025-09-28T10:38:00.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    Revision: v3.0.2 replaces v3.0.1; Back to Top UI element removed.
    Difference
    0.2%
    Check dated 2025-09-14T00:34:05.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.
    Difference
    0.2%
    Check dated 2025-09-06T21:10:16.000Z thumbnail image
  8. Check
    73 days ago
    Change Detected
    Summary
    The web page has undergone significant changes, including the addition of a facility name and location details, while key information about previous location terms and specific medical topics has been removed.
    Difference
    3%
    Check dated 2025-08-30T15:34:40.000Z thumbnail image

Stay in the know with updates to Pegilodecakin Combo vs Pembrolizumab Alone in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pegilodecakin Combo vs Pembrolizumab Alone in NSCLC Clinical Trial page.